These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26093158)

  • 1. The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.
    Ham AS; Nugent ST; Peters JJ; Katz DF; Shelter CM; Dezzutti CS; Boczar AD; Buckheit KW; Buckheit RW
    Antiviral Res; 2015 Aug; 120():153-64. PubMed ID: 26093158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention.
    Dezzutti CS; Shetler C; Mahalingam A; Ugaonkar SR; Gwozdz G; Buckheit KW; Buckheit RW
    Antiviral Res; 2012 Nov; 96(2):221-5. PubMed ID: 22940075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection.
    Ham AS; Rohan LC; Boczar A; Yang L; W Buckheit K; Buckheit RW
    Pharm Res; 2012 Jul; 29(7):1897-907. PubMed ID: 22392331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques.
    Pereira LE; Mesquita PM; Ham A; Singletary T; Deyounks F; Martin A; McNicholl J; Buckheit KW; Buckheit RW; Smith JM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1393-400. PubMed ID: 26666935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal Microbicide Film Combinations of Two Reverse Transcriptase Inhibitors, EFdA and CSIC, for the Prevention of HIV-1 Sexual Transmission.
    Zhang W; Hu M; Shi Y; Gong T; Dezzutti CS; Moncla B; Sarafianos SG; Parniak MA; Rohan LC
    Pharm Res; 2015 Sep; 32(9):2960-72. PubMed ID: 25794967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.
    Mahalingam A; Simmons AP; Ugaonkar SR; Watson KM; Dezzutti CS; Rohan LC; Buckheit RW; Kiser PF
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1650-60. PubMed ID: 21245437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission.
    Ugaonkar SR; Clark JT; English LB; Johnson TJ; Buckheit KW; Bahde RJ; Appella DH; Buckheit RW; Kiser PF
    J Pharm Sci; 2015 Oct; 104(10):3426-39. PubMed ID: 26149293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.
    Johnson TJ; Srinivasan P; Albright TH; Watson-Buckheit K; Rabe L; Martin A; Pau CP; Hendry RM; Otten R; McNicholl J; Buckheit R; Smith J; Kiser PF
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1291-9. PubMed ID: 22155820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and delivery of anti-HIV rectal microbicides: advances and challenges.
    Nunes R; Sarmento B; das Neves J
    J Control Release; 2014 Nov; 194():278-94. PubMed ID: 25229988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.
    Srinivasan P; Zhang J; Martin A; Kelley K; McNicholl JM; Buckheit RW; Smith JM; Ham AS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4140-50. PubMed ID: 27139475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation.
    Di Fabio S; Van Roey J; Giannini G; van den Mooter G; Spada M; Binelli A; Pirillo MF; Germinario E; Belardelli F; de Bethune MP; Vella S
    AIDS; 2003 Jul; 17(11):1597-604. PubMed ID: 12853741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.
    Pereira LE; Singletary T; Martin A; Dinh CT; Deyounks F; Holder A; McNicholl J; Buckheit KW; Buckheit RW; Ham A; Katz DF; Smith JM
    Drug Deliv Transl Res; 2018 Oct; 8(5):1180-1190. PubMed ID: 29761350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.
    McGowan I; Taylor DJ
    Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV.
    Buckheit KW; Furlan-Freguia C; Ham AS; Buckheit RW
    Curr Top Med Chem; 2016; 16(10):1118-34. PubMed ID: 26324047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges.
    Garg S; Tambwekar KR; Vermani K; Kandarapu R; Garg A; Waller DP; Zaneveld LJ
    AIDS Patient Care STDS; 2003 Aug; 17(8):377-99. PubMed ID: 13678540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.